Andrew von Eschenbach, President Bush's nominee to head the Food and Drug Administration, finally got his chance to make his case before a Senate committee.
But his fate is now wrapped up in a fight over whether to approve over-the-counter access to the so-called morning-after birth-control pill -- as well as broader questions about the intersection of science and politics.
Copyright 2023 NPR. To see more, visit https://www.npr.org.
